Posted by 
Introduction
Have you seen the Film Limitless? The film is about cognition enhancing drugs, or one particular cognition enhancing drug, the mysterious NZT-48. In the film, Eddie Mora, played by Bradley Cooper, is a struggling who takes the drug and gets an amazing boost to his mental abilities.
So here’s the question: if you were offered such a drug, would you take it?
Let’s say you are 18 and about to take your A Levels (for my overseas readers, enter your country’s university entrance qualifications). You need top grades to get into Oxford (again, overseas readers, enter one of your country’s top universities). You’re good, very good but can you get those top grades?
Perhaps you’re an outstanding chess player, but not quite a grandmaster.
Or, you might be climbing the corporate ladder and the competition is fierce.
Or, you’ve just been told you have Alzheimer’s disease, the most common form of dementia.
Okay, so in reality we are not quite in the world of Limitless and today’s cognitive enhancing drugs will not turn you into Eddie Mora. But, today’s science fiction is tomorrow’s science fact.
So, to ask the question again: if you could, would you take a cognition enhancing drug?
The Ageing Mind
As you age, you might wonder about ways to keep your mind sharp. Once more, would you consider cognition enhancing drugs?
These drugs, like methylphenidate and modafinil, are causing a revolution in how we think about brain health for older adults. They promise to boost concentration, working memory, and overall cognitive function. But before you get excited, it’s important to consider the ethical issues that come with using these medications.
When it comes to cognitive enhancers for the elderly, there’s a lot to unpack. You’ll need to think about whether these drugs are a treatment or an enhancement, and how they might affect a person’s identity.
There are also questions about fairness and who gets access to these medications. As we dive into this topic, we’ll explore the science behind these drugs, their potential side effects, and the ethical considerations that come with their use. By the end, you’ll have a clearer picture of the complex landscape surrounding cognition enhancing medication for older adults.
Cognitive Enhancement: Treatment or Enhancement?
When you think about cognition enhancing medication, you might wonder: Is this a treatment or an enhancement? The line between the two isn’t always clear. Let’s explore this complex issue and its implications for dementia care.
Defining the treatment-enhancement boundary
The use of cognitive enhancers, often called “smart drugs,” has become more widespread. These include medications like modafinil, piracetam, and methylphenidate. While they’re meant to boost cognitive abilities, their use raises ethical concerns. There’s a debate about whether these drugs are treating a condition or simply enhancing normal function.
It’s important to consider the potential risks. These medications can have side effects, including dependence, tolerance, and various health issues. The benefits for cognitive enhancement are still up for debate, making the risk-benefit analysis crucial.
Goals of cognitive enhancement in dementia
For people with dementia, cognitive enhancement has a specific purpose. The aim is to slow down the decline in memory and thinking skills. Anti-amyloid treatments, for example, work by removing beta-amyloid protein from the brain. These treatments have shown promise in slowing cognitive decline in early stages of Alzheimer’s disease.
Other medications, like cholinesterase inhibitors, are used to treat symptoms related to memory and thinking processes. They work by preventing the breakdown of acetylcholine, a chemical messenger important for learning and memory.
Implications for medical practice
The growing interest in cognitive enhancement has significant implications for medical practice. In Italy, for instance, the medical code now allows for enhancement practices, as long as they meet ethical and clinical criteria. Doctors are required to prioritize human dignity, identity, and integrity when prescribing these treatments.
Informed consent is crucial. Doctors must explain all possible risks and obtain written consent before proceeding with any cognitive enhancement treatment. They’re also expected to turn down requests for treatments they consider too risky or disproportionate.
As you consider cognitive enhancement options, remember that a healthy lifestyle remains a key factor. Engaging in social and intellectual activities, maintaining a balanced diet, and regular exercise can all contribute to cognitive health. These natural approaches might be a safer starting point before considering pharmacological interventions.
Personhood, Identity, and Cognitive Enhancement
When you think about cognitive enhancement for people with dementia, it’s not just about improving memory or thinking skills. It’s also about how these changes might affect a person’s sense of self and identity. Let’s explore this complex issue.
Concepts of self in dementia
You might wonder if people with dementia lose their sense of self. Research shows it’s not that simple. While some aspects of self are affected, others remain even in advanced stages of dementia. Some people with dementia still feel “the same” as before their diagnosis.
The self isn’t just one thing. It’s made up of different parts:
- The feeling that we exist
- Who we are as individuals
- Who we are in relation to others
Interestingly, the first aspect – the basic sense of existing – doesn’t seem to be affected by dementia. However, the other two aspects can change as the condition progresses.
Effects of cognitive enhancement on personality
Cognitive enhancers might change how a person with dementia thinks and behaves. This could affect their personality and how they interact with others. For example, if someone becomes more aware of their condition, it might change how they see themselves and how they relate to those around them.
Authenticity and enhanced cognition
You might ask: If cognitive enhancers change how a person thinks or acts, are they still being their “true” self? This is where the concept of authenticity comes in. Authenticity is about being true to oneself, but it’s also about how others see us.
For people with dementia, authenticity can be tricky. Changes in the brain can affect self-awareness and behaviour. In some types of dementia, like frontotemporal dementia, a person might act in ways that seem out of character to those who know them.
Cognitive enhancement might help preserve some aspects of a person’s identity. But it’s important to consider whether the changes align with who the person was before their diagnosis. The goal is to support the person’s sense of self, not to create a version of them that doesn’t feel authentic.
Social Justice and Access to Cognitive Enhancers
When you think about cognitive enhancers, you might wonder who gets access to these medications and why. This question brings up important issues of social justice and fairness.
Socioeconomic factors in access
Your access to cognitive enhancers may depend on your social and economic situation. For instance, your education level can play a big role in your brain health. Studies show that college graduates are less likely to experience cognitive decline compared to those without a high school diploma. Also, having regular access to healthcare services gives you a better chance of early diagnosis and treatment of conditions that affect brain health.
Potential for exacerbating inequalities
The use of cognitive enhancers could widen the gap between different groups in society. If these medications become widely available, those who are already better off might gain even more advantages. This could lead to a situation where an “enhanced cognitive elite” gains more power and influence.
However, it’s not all doom and gloom. Some experts suggest that genetic enhancements might actually help those who are genetically worse off in society. This could potentially level the playing field and provide more equal opportunities.
Ethical approaches to fair distribution
To address these concerns, we need to think about fair ways to distribute cognitive enhancers. One approach could be similar to affirmative action policies, which aim to prevent inequalities from growing larger. Companies might even consider providing free access to cognitive enhancers for their employees, just like they often provide free coffee.
It’s also important to consider that equal access doesn’t guarantee equal outcomes. Even if everyone had the same access to cognitive enhancers, people might still benefit differently based on their existing cognitive abilities and prior learning experiences.
As we move forward, it’s crucial to find ways to use cognitive enhancers that correct existing inequalities rather than making them worse. This might mean focusing on helping those who are already at a disadvantage, rather than just enhancing those who are already doing well.
Cognitive Enhancing Drugs and The Future
The future of cognitive-enhancing drugs holds the potential to revolutionize how we think, learn, and interact with the world. As research in neuroscience and pharmacology advances, the possibility of developing drugs that significantly enhance brain function is becoming increasingly plausible. Imagine a world where cognitive enhancers could not only sharpen memory and focus but also dramatically accelerate learning, improve problem-solving skills, and even unlock new levels of creativity and intelligence.
The film Limitless introduced audiences to the fictional drug NZT-48, a pill that grants its user superhuman mental abilities, enabling them to access every part of their brain and vastly outperform others in virtually any intellectual task. While NZT-48 remains a work of fiction, it serves as an intriguing exploration of what the future could hold. In reality, today’s cognitive enhancers like modafinil and methylphenidate offer a glimpse into this future, boosting alertness, concentration, and memory, but without the dramatic, all-encompassing effects seen in the film.
As science progresses, however, the gap between reality and fiction may begin to narrow. Emerging research in neurotechnology, brain-computer interfaces, and personalized medicine suggests that future cognitive enhancers could be designed to target specific neural pathways with unprecedented precision. These drugs might someday enable individuals to optimize their brain function far beyond what is currently possible, approaching a state that, while not identical to NZT-48, could offer similarly profound cognitive enhancements.
Of course, this potential raises ethical questions about who would have access to such powerful drugs and how they would be regulated. The implications for society, education, and the workforce are vast, with the possibility of creating a cognitive elite or exacerbating existing inequalities. As we edge closer to the capabilities imagined in Limitless, it’s crucial to consider both the incredible opportunities and the significant challenges that such advancements would bring.
Conclusion
The use of cognitive enhancers for dementia in the elderly brings up a host of ethical questions that don’t have easy answers. We’ve looked at whether these drugs are treatments or enhancements, how they might change a person’s sense of self, and the fairness issues around who gets access to them. These are complex issues that touch on science, ethics, and social justice.
As we move forward, it’s crucial to keep having conversations about the pros and cons of cognitive enhancers. We need to find a balance between helping those with dementia and making sure we’re not creating new problems or making existing inequalities worse. To wrap up, I’d encourage you to keep thinking about these issues and how they might affect you or your loved ones. Leave a comment with your experiences – your thoughts could help shape this ongoing discussion.